- Home
- BPMC vs CVLT Comparison
BPMC vs CVLT Comparison
Compare BPMC & CVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- CVLT
- Stock Information
- Founded
- BPMC 2008
- CVLT 1996
- Country
- BPMC United States
- CVLT United States
- Employees
- BPMC N/A
- CVLT N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- CVLT Computer Software: Prepackaged Software
- Sector
- BPMC Health Care
- CVLT Technology
- Exchange
- BPMC Nasdaq
- CVLT Nasdaq
- Market Cap
- BPMC 5.9B
- CVLT 5.9B
- IPO Year
- BPMC 2015
- CVLT 2006
- Fundamental
- Price
- BPMC $90.14
- CVLT $158.73
- Analyst Decision
- BPMC Buy
- CVLT Buy
- Analyst Count
- BPMC 20
- CVLT 8
- Target Price
- BPMC $120.79
- CVLT $155.43
- AVG Volume (30 Days)
- BPMC 667.8K
- CVLT 328.9K
- Earning Date
- BPMC 02-13-2025
- CVLT 01-28-2025
- Dividend Yield
- BPMC N/A
- CVLT N/A
- EPS Growth
- BPMC N/A
- CVLT N/A
- EPS
- BPMC N/A
- CVLT 3.94
- Revenue
- BPMC $434,415,000.00
- CVLT $898,050,000.00
- Revenue This Year
- BPMC $108.09
- CVLT $16.12
- Revenue Next Year
- BPMC $39.34
- CVLT $11.54
- P/E Ratio
- BPMC N/A
- CVLT $40.31
- Revenue Growth
- BPMC 100.93
- CVLT 12.58
- 52 Week Low
- BPMC $72.24
- CVLT $73.33
- 52 Week High
- BPMC $121.90
- CVLT $178.72
- Technical
- Relative Strength Index (RSI)
- BPMC 42.11
- CVLT 38.20
- Support Level
- BPMC $86.02
- CVLT $157.58
- Resistance Level
- BPMC $98.41
- CVLT $176.67
- Average True Range (ATR)
- BPMC 3.28
- CVLT 4.84
- MACD
- BPMC -0.76
- CVLT -2.35
- Stochastic Oscillator
- BPMC 33.04
- CVLT 14.15
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About CVLT Commvault Systems Inc.
CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Commvault Complete Backup and Recovery, HyperScale, Hedvig, and Metallic. The company operates in the United States and exports to many other countries.